Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,969,104
-$13,199,789 QoQ
Shares Held
608,746
-25.1% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#50
of 712 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JONES FINANCIAL COMPANIES LLLP holds $2,915,385,555 across 19 Drug Manufacturers - General names. SNY ranks #12 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
746,099 | $894,893,598 | |
| 2 | JNJ |
Johnson & Johnson
|
1,814,780 | $460,899,675 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,548,737 | $327,512,704 | |
| 4 | AZN |
Astrazeneca PLC
|
1,670,876 | $316,831,506 | |
| 5 | NVS |
Novartis AG
|
1,974,043 | $309,372,018 | |
| 6 | ABBV |
AbbVie Inc.
|
988,813 | $248,824,903 | |
| 7 | PFE |
Pfizer Inc
|
4,638,683 | $111,699,485 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
502,809 | $63,524,888 |
All Filings in SNY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,969,104 | 608,746 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $39,168,893 | 812,970 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,831,448 | 37,793 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,406,748 | 29,804 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,264,900 | 26,183 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $998,335 | 18,001 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $729,333 | 15,122 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $562,238 | 9,756 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $221,930 | 4,574 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $193,330 | 3,978 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $52,216 | 1,050 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $18,934 | 353 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $12,843 | 236 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,065 | 22 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $29,267 | 585 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $27,004 | 526 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $28,206 | 563 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $27,142 | 563 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $29,647 | 563 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $49,954 | 1,010 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $31,049 | 639 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||